Recombinant human erythropoietin for treating severe traumatic brain injury

BACKGROUND: This study aimed to explore the efficacy and safety of recombinant human erythropoietin (RHE) for the treatment of severe traumatic brain injury (STBI). METHODS: One hundred and twenty eligible patients with STBI were randomly divided into an intervention group or a control group equally...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Xiao-Fei, Gao, Yong-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943123/
https://www.ncbi.nlm.nih.gov/pubmed/29505528
http://dx.doi.org/10.1097/MD.0000000000009532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943123/
https://www.ncbi.nlm.nih.gov/pubmed/29505528
http://dx.doi.org/10.1097/MD.0000000000009532

Ejemplares similares